key: cord-1050075-jb8tyguk
authors: Chuzi, Sarah; Molsberry, Rebecca; McCabe, Megan E.; Yancy, Clyde W.; Ogunseitan, Adeboye; Allen, Norrina B.; Khan, Sadiya S.
title: Distribution in Place of Death for Coronavirus 2019 (COVID‐19)‐Related Mortality in the United States
date: 2020-07-09
journal: J Am Geriatr Soc
DOI: 10.1111/jgs.16721
sha: 6ba12aa55ad789d0499222fcc78d450c92898a0f
doc_id: 1050075
cord_uid: jb8tyguk

nan

Coronavirus disease 2019 (COVID-19) has resulted in considerable mortality in the United States (US), exceeding 100,000 deaths to-date. While much attention has been devoted to the clinical challenges in management of critically ill patients with COVID-19, less is known about the end-of-life experience.

Place of death is an important determinant of quality of care and patient and caregiver experience. Therefore, we sought to examine the distribution of place of COVID-19-related deaths in the US.

We analyzed publicly available data released by the Centers for Disease Control (CDC) for COVID-19 deaths from 2/1/2020 (prior to the first US COVID-19 death on 2/6/20) 1 through 5/23/2020. COVID-19related deaths were identified whereby COVID-19 (ICD10: U07.1) was reported as a cause of death (including "probable" or "presumed" cause). We calculated the proportion of COVID-19-related deaths that occurred in the locations of medical facility, nursing facility, home, and hospice facility using place of death noted on the death certificate. Next, we determined the proportions of all-cause historical deaths in each location over a similar length of time in 2018 (2/1/2018 to 5/31/2018) using the CDC's Wide-Ranging Online Data for Epidemiologic Research database 2 and compared them with COVID-19 distributions using chi-square tests. Odds ratios were calculated to determine the odds of death occurring in a medical facility (versus home) for COVID-19-related deaths in 2020 versus all-cause deaths in 2018.

Between 2/1/2020 and 5/23/2020, 81,372 deaths from COVID-19 were reported by the CDC (54% men, 23% black, 81%  65 years). The proportions of COVID-19-related deaths occurring in medical facilities, nursing facilities, homes, and hospice were 68.7%, 22.7%, 5.2%, and 1.9%, respectively. At the statelevel, Wisconsin had the highest proportion of home deaths (9% of 452 deaths) followed by New York (8% of 26,619 deaths). In several states the proportion of deaths in nursing facilities was higher than the proportion occurring in medical facilities, including Minnesota (60% in nursing facilities, 34% in medical This article is protected by copyright. All rights reserved. Accepted Article facilities, 745 total deaths), New Hampshire (59% in nursing facilities, 41% in medical facilities, 169 total deaths) and Rhode Island (52% in nursing facilities, 32% in medical facilities, 401 total deaths). For historical comparison, of the 947,739 deaths from all causes reported between 2/1/2018-5/31/2018, the proportion occurring in medical facilities, nursing facilities, homes, and hospice was 35.7%, 19.1%, 31.1%, and 7.9%, respectively (p < 0.001 for each location versus COVID-19-related deaths) (Figure 1) .

The odds of dying in a medical facility versus home was 11.5 times greater for COVID-19-related deaths in 2020 compared with all-cause deaths in 2018 (95% CI 11.1-11.8).

The majority of US patients with mortality attributed to COVID-19 died in a medical facility, which is consistent with the clinical profile of a rapidly progressive illness. We observed state-level variation in location of death, which may be related to differences in hospital capacity (leading to more deaths outside of medical facilities) and availability of protective equipment, or suboptimal infection control (leading to more deaths in nursing facilities). While recent work has demonstrated that US deaths in medical facilities are decreasing and deaths at home and in hospice facilities are increasing, the burden of deaths attributed to COVID-19 may reverse these overall trends. 3, 4 Limitations of these data include reliance on provisional death certificate data for cause and location of death. Further, significant excess mortality not attributed to COVID-19 during this time period has also been reported, 5 but the location of these deaths or their influence on place of death proportions is not yet known. Nonetheless, we describe an important aspect of the ongoing COVID-19 pandemic, highlighting the need to discuss and promote patient-centered care at the end-of-life.

National Center for Health Statistics. Provisional COVID-19 Death Counts by Place of Death and State

Sickle cell disease related mortality in the United States

Changes in place of death in the United States

Trends in place of death for cardiovascular mortality related to heart failure in the United States from

Figure 1: Distribution in location of death for COVID-19-related (2/1/2020-5/23/2020) and allcause (2/1/2018-5/30/2018) mortality in the United States Distribution in location of death for COVID-19-related (2/1/2020-5/23/2020) and all-cause (2/1/2018-5/30/2018) mortality in the United States